1224508-84-2

Basic information

• Product Name: 4-((3,3-dimethylbutoxy)carbonyloxy)benzyl 2-(2-(2,6-dichlorophenylamino)phenyl)acetate
• Synonyms: 4-((3,3-dimethylbutoxy)carbonyloxy)benzyl 2-(2-(2,6-dichlorophenylamino)phenyl)acetate
• CAS NO: 1224508-84-2
• Molecular Weight: 530.448
• Mol File: 1224508-84-2.mol
• Article Data: 2

Chemical Properties

• CAS DataBase Reference: 4-((3,3-dimethylbutoxy)carbonyloxy)benzyl 2-(2-(2,6-dichlorophenylamino)phenyl)acetate(CAS DataBase Reference)
• NIST Chemistry Reference: 4-((3,3-dimethylbutoxy)carbonyloxy)benzyl 2-(2-(2,6-dichlorophenylamino)phenyl)acetate(1224508-84-2)
• EPA Substance Registry System: 4-((3,3-dimethylbutoxy)carbonyloxy)benzyl 2-(2-(2,6-dichlorophenylamino)phenyl)acetate(1224508-84-2)

Safety Data

• Hazardous Substances Data: 1224508-84-2(Hazardous Substances Data)

Upstream product

• 1224508-72-8 3,3-dimethylbutyl 4-(hydroxymethyl)phenyl carbonate 
• 15307-86-5 [2-(2,6-dichloroanilino)phenyl]acetic acid 

Downstream Products

• 15307-86-5 [2-(2,6-dichloroanilino)phenyl]acetic acid 

Relevant articles and documents

UNIQUE DUAL-ACTION THERAPEUTICS

A new family of therapeutics which provides a controlled-release delivery platform for non-steroidal anti-inflammatory agents on an ester or an ester-carbonate backbone is disclosed herein. These agents are reversible inhibitors of acetylcholinesterase and are thus useful for clinical conditions benefiting from inflammation suppression and cholinergic intervention. These compounds are of the general formula wherein n = 0, 1; X = C, Si, and N+ and NSAID = ibuprofen, naproxen, indomethacin and diclofenac. Other embodiments are also disclosed